ONO Pharmaceutical Co., Ltd.ONO Pharmaceutical Co., Ltd.ONO Pharmaceutical Co., Ltd.

ONO Pharmaceutical Co., Ltd.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪4.84 B‬EUR
0.538EUR
‪308.37 M‬EUR
‪3.00 B‬EUR
‪332.30 M‬
Beta (1Y)
0.34
Employees (FY)
‪4.29 K‬
Change (1Y)
+434 +11.26%
Revenue / Employee (1Y)
Net income / Employee (1Y)

About ONO Pharmaceutical Co., Ltd.


CEO
Gyo Sagara
Headquarters
Osaka
Founded
1717
ISIN
JP3197600004
FIGI
BBG000C4Q9Y2
Ono Pharmaceutical Co., Ltd. engages in the production, purchase, and sale of internal medicine, patch and injectable medicine. The company was founded by Ichibei Fushimiya in 1717 and is headquartered in Osaka, Japan.

Check out other big names from the same industry as ON4.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
1306
Next Funds TOPIX Exchange Traded Fund
Weight
0.08%
Market value
‪144.73 M‬
USD
1308
Nikko Exchange Traded Index Fund TOPIX
Weight
0.08%
Market value
‪69.07 M‬
USD
1305
iFreeETF TOPIX
Weight
0.08%
Market value
‪62.98 M‬
USD
SCHY
Schwab International Dividend Equity ETF
Weight
4.01%
Market value
‪55.79 M‬
USD
VEA
Vanguard FTSE Developed Markets ETF
Weight
0.02%
Market value
‪41.80 M‬
USD
IEFA
iShares Core MSCI EAFE ETF
Weight
0.02%
Market value
‪30.22 M‬
USD
1348
MAXIS TOPIX ETF
Weight
0.08%
Market value
‪20.70 M‬
USD
DFIV
Dimensional International Value ETF
Weight
0.12%
Market value
‪16.94 M‬
USD
BBJP
JPMorgan BetaBuilders Japan ETF
Weight
0.11%
Market value
‪15.97 M‬
USD
SCZ
iShares MSCI EAFE Small-Cap ETF
Weight
0.14%
Market value
‪14.48 M‬
USD
ZPRG
SPDR S&P Global Dividend Aristocrats UCITS ETF
Weight
1.04%
Market value
‪14.40 M‬
USD

Explore more ETFs 

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange ONO Pharmaceutical Co., Ltd. stocks are traded under the ticker ON4.
We've gathered analysts' opinions on ONO Pharmaceutical Co., Ltd. future price: according to them, ON4 price has a max estimate of 10.14 EUR and a min estimate of 7.32 EUR. Watch ON4 chart and read a more detailed ONO Pharmaceutical Co., Ltd. stock forecast: see what analysts think of ONO Pharmaceutical Co., Ltd. and suggest that you do with its stocks.
ON4 reached its all-time high on Jul 14, 2022 with the price of 27.600 EUR, and its all-time low was 8.950 EUR and was reached on Jul 8, 2025. View more price dynamics on ON4 chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track ONO Pharmaceutical Co., Ltd. financials in yearly and quarterly reports right on TradingView.
ONO Pharmaceutical Co., Ltd. is going to release the next earnings report on Oct 30, 2025. Keep track of upcoming events with our Earnings Calendar.
ON4 earnings for the last quarter are 0.22 EUR per share, whereas the estimation was 0.29 EUR resulting in a −23.95% surprise. The estimated earnings for the next quarter are 0.23 EUR per share. See more details about ONO Pharmaceutical Co., Ltd. earnings.
ONO Pharmaceutical Co., Ltd. revenue for the last quarter amounts to ‪751.26 M‬ EUR, despite the estimated figure of ‪702.29 M‬ EUR. In the next quarter, revenue is expected to reach ‪703.53 M‬ EUR.
ON4 net income for the last quarter is ‪103.61 M‬ EUR, while the quarter before that showed ‪−40.33 M‬ EUR of net income which accounts for 356.91% change. Track more ONO Pharmaceutical Co., Ltd. financial stats to get the full picture.
ONO Pharmaceutical Co., Ltd. dividend yield was 4.99% in 2024, and payout ratio reached 75.08%. The year before the numbers were 3.26% and 30.01% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Oct 18, 2025, the company has ‪4.29 K‬ employees. See our rating of the largest employees — is ONO Pharmaceutical Co., Ltd. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ONO Pharmaceutical Co., Ltd. EBITDA is ‪512.84 M‬ EUR, and current EBITDA margin is 18.54%. See more stats in ONO Pharmaceutical Co., Ltd. financial statements.
Like other stocks, ON4 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ONO Pharmaceutical Co., Ltd. stock right from TradingView charts — choose your broker and connect to your account.